ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the first patient dosed in...
QPharma, the leading provider of cloud-based compliance solutions, unveiled Ti CRM®, a CRM for fast implementations. Ti CRM 2.0 is the next generation of...
Exact Sciences Corp. (NASDAQ: EXAS) announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer...
Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole...
A2 Biotherapeutics, Inc. ("A2 Bio") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to...
